Knight Therapeutics, Inc. (GUD.TO)
8.19
+0.24
(+3.02%)
CAD |
TSX |
May 29, 16:00
Knight Therapeutics Price : 8.19 for May 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 4.59 |
| Bausch Health Cos., Inc. | 7.41 |
| Cipher Pharmaceuticals, Inc. | 16.69 |
| BioSyent, Inc. | 13.96 |
| Revive Therapeutics Ltd. | 0.035 |
Price Related Metrics
| PE Ratio | 141.94 |
| PS Ratio | 1.594 |
| Price to Book Value | 1.021 |
| Price to Free Cash Flow | 12.13 |
| Earnings Yield | 0.70% |
| Market Cap | 804.09M |
| Operating PE Ratio | 59.11 |
| Normalized PE Ratio | 100.37 |